MX2008008050A - Suministro transdermico de meptazinol. - Google Patents
Suministro transdermico de meptazinol.Info
- Publication number
- MX2008008050A MX2008008050A MX2008008050A MX2008008050A MX2008008050A MX 2008008050 A MX2008008050 A MX 2008008050A MX 2008008050 A MX2008008050 A MX 2008008050A MX 2008008050 A MX2008008050 A MX 2008008050A MX 2008008050 A MX2008008050 A MX 2008008050A
- Authority
- MX
- Mexico
- Prior art keywords
- meptazinol
- transdermal delivery
- increases
- disclosed
- analgesic relief
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Se describe un sistema de administración para suministrar una sal de meptazinol o precursor de meptazinol que incrementa la biodisponibilidad del meptazinol al proporcionar una cantidad efectiva para alivio analgésico. Una modalidad del sistema de administración es un dispositivo transcutáneo el cual incrementa el flujo de meptazinol en la piel al proporcionar una cantidad efectiva para alivio analgésico. También se describen métodos para proporcionar alivio analgésico.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75335705P | 2005-12-21 | 2005-12-21 | |
US86211406P | 2006-10-19 | 2006-10-19 | |
PCT/US2006/048783 WO2007075883A2 (en) | 2005-12-21 | 2006-12-21 | Transdermal delivery of meptazinol |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2008008050A true MX2008008050A (es) | 2009-04-06 |
Family
ID=38198475
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2008008050A MX2008008050A (es) | 2005-12-21 | 2006-12-21 | Suministro transdermico de meptazinol. |
Country Status (15)
Country | Link |
---|---|
US (1) | US20070224253A1 (es) |
EP (1) | EP1962817B1 (es) |
AR (1) | AR058598A1 (es) |
AT (1) | ATE488229T1 (es) |
AU (1) | AU2006331596A1 (es) |
CA (1) | CA2633369A1 (es) |
DE (1) | DE602006018355D1 (es) |
DK (1) | DK1962817T3 (es) |
EA (1) | EA200801575A1 (es) |
MX (1) | MX2008008050A (es) |
PE (1) | PE20071163A1 (es) |
PT (1) | PT1962817E (es) |
TW (1) | TW200800223A (es) |
UY (1) | UY30056A1 (es) |
WO (1) | WO2007075883A2 (es) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090280064A1 (en) * | 2005-06-24 | 2009-11-12 | Rao Papineni | Transdermal delivery of optical, spect, multimodal, drug or biological cargo laden nanoparticle(s) in small animals or humans |
WO2008079440A2 (en) | 2006-07-10 | 2008-07-03 | Medipacs, Inc. | Super elastic epoxy hydrogel |
US9995295B2 (en) | 2007-12-03 | 2018-06-12 | Medipacs, Inc. | Fluid metering device |
WO2009092073A2 (en) * | 2008-01-18 | 2009-07-23 | Shire Llc | Amino acid and peptide prodrugs of opioid analgesics with reduced gi side-effects |
AU2009262967C1 (en) * | 2008-06-25 | 2015-12-24 | Fe3 Medical, Inc | Patches and methods for the transdermal delivery of a therapeutically effective amount of iron |
US8190252B2 (en) | 2009-02-12 | 2012-05-29 | Incube Labs, Llc | Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes |
US8961492B2 (en) | 2009-02-12 | 2015-02-24 | Incube Labs, Llc | System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation |
US8348922B2 (en) * | 2009-02-12 | 2013-01-08 | Incube Labs, Llc | Method and apparatus for oscillatory iontophoretic transdermal delivery of a therapeutic agent |
US8821945B2 (en) | 2009-04-25 | 2014-09-02 | Fe3 Medical, Inc. | Method for transdermal iontophoretic delivery of chelated agents |
US8423131B2 (en) * | 2009-06-26 | 2013-04-16 | Incube Labs, Llc | Corrosion resistant electrodes for iontophoretic transdermal delivery devices and methods of use |
US8903485B2 (en) * | 2009-08-06 | 2014-12-02 | Incube Labs, Llc | Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes |
WO2011032011A1 (en) | 2009-09-10 | 2011-03-17 | Medipacs, Inc. | Low profile actuator and improved method of caregiver controlled administration of therapeutics |
US8685038B2 (en) | 2009-12-07 | 2014-04-01 | Incube Labs, Llc | Iontophoretic apparatus and method for marking of the skin |
US9500186B2 (en) | 2010-02-01 | 2016-11-22 | Medipacs, Inc. | High surface area polymer actuator with gas mitigating components |
EP2531047A4 (en) | 2010-02-05 | 2014-03-19 | Phosphagenics Ltd | CARRIER WITH AN UNINUTRALIZED TOCOPHERYL PHOSPHATE |
WO2011100376A2 (en) | 2010-02-10 | 2011-08-18 | Incube Labs, Llc | Methods and architecture for power optimization of iontophoretic transdermal drug delivery |
ES2829386T3 (es) | 2010-03-30 | 2021-05-31 | Phosphagenics Ltd | Parche de administración transdérmica |
US8668675B2 (en) | 2010-11-03 | 2014-03-11 | Flugen, Inc. | Wearable drug delivery device having spring drive and sliding actuation mechanism |
EP2685992A4 (en) | 2011-03-15 | 2014-09-10 | Phosphagenics Ltd | AMINO-QUINOLINES AS KINASE INHIBITORS |
JP6133843B2 (ja) | 2011-03-24 | 2017-05-31 | インキューブ ラブズ,リミテッド ライアビリティー カンパニーInCube Labs,LLC | 治療剤の二相性経皮イオン泳動送達用のシステム及び方法 |
WO2012154704A2 (en) | 2011-05-06 | 2012-11-15 | Incube Labs, Llc | System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings |
US8636696B2 (en) | 2011-06-10 | 2014-01-28 | Kimberly-Clark Worldwide, Inc. | Transdermal device containing microneedles |
EP2847249A4 (en) | 2012-03-14 | 2016-12-28 | Medipacs Inc | SMART POLYMER MATERIALS WITH EXCESSIVE REACTIVE MOLECULES |
US9861801B2 (en) | 2013-02-28 | 2018-01-09 | Kimberly-Clark Worldwide, Inc. | Drug delivery device |
MX360121B (es) | 2013-02-28 | 2018-10-03 | Kimberly Clark Co | Dispositivo de administración transdérmica de fármacos. |
US10376308B2 (en) | 2015-02-05 | 2019-08-13 | Axon Therapies, Inc. | Devices and methods for treatment of heart failure by splanchnic nerve ablation |
CA3007587C (en) | 2015-12-09 | 2023-12-05 | Phosphagenics Limited | Pharmaceutical formulation |
EP3490442A4 (en) | 2016-07-29 | 2020-03-25 | Axon Therapies, Inc. | DEVICES, SYSTEMS AND METHODS FOR THE TREATMENT OF HEART FAILURE BY ABLATION OF SPLANCHNIC NERVE |
WO2018112512A1 (en) | 2016-12-21 | 2018-06-28 | Phosphagenics Limited | Process |
US10561461B2 (en) | 2017-12-17 | 2020-02-18 | Axon Therapies, Inc. | Methods and devices for endovascular ablation of a splanchnic nerve |
WO2019148094A1 (en) | 2018-01-26 | 2019-08-01 | Axon Therapies, Inc. | Methods and devices for endovascular ablation of a splanchnic nerve |
AU2020296866A1 (en) | 2019-06-20 | 2021-10-14 | Axon Therapies, Inc. | Methods and devices for endovascular ablation of a splanchnic nerve |
JP2023510597A (ja) | 2020-01-17 | 2023-03-14 | アクソン セラピーズ,インク. | 内臓神経の血管内アブレーションの方法及びデバイス |
CN113491675B (zh) * | 2021-07-01 | 2023-05-23 | 北京航空航天大学 | 一种预防瘢痕的微针创口贴及其制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1539277A (en) * | 1977-09-16 | 1979-01-31 | Wyeth John & Brother Ltd | Hexahydro-1h-azepines |
IE55189B1 (en) * | 1982-07-08 | 1990-06-20 | Wyeth John & Brother Ltd | Pharmaceutical compositions |
IE60941B1 (en) * | 1986-07-10 | 1994-09-07 | Elan Transdermal Ltd | Transdermal drug delivery device |
US6916486B2 (en) * | 1996-02-19 | 2005-07-12 | Acrux Dds Pty Ltd | Transdermal delivery of analgesics |
JP2002519366A (ja) * | 1998-07-07 | 2002-07-02 | トランスダーマル・テクノロジーズ・インコーポレーテツド | 医薬的に活性な作用物質を迅速かつ非刺激的に経皮送達するための組成物、およびそのような組成物の調剤法およびそれらの送達 |
US6716449B2 (en) * | 2000-02-08 | 2004-04-06 | Euro-Celtique S.A. | Controlled-release compositions containing opioid agonist and antagonist |
DE10059415A1 (de) * | 2000-11-30 | 2002-06-06 | Gruenenthal Gmbh | Verwendung von schwachen Opioiden und gemischten Opioidagonisten/-antagonisten zur Therapie der Harninkontinenz |
ATE423560T1 (de) * | 2002-08-20 | 2009-03-15 | Euro Celtique Sa | Transdermale dosierungsform enthaltend einen wirkstoff und einen antagonisten in freier base und in salz form |
CA2522529C (en) * | 2003-04-30 | 2015-10-20 | Purdue Pharma L.P. | Tamper resistant transdermal dosage form |
-
2006
- 2006-12-20 TW TW095147948A patent/TW200800223A/zh unknown
- 2006-12-21 EP EP06848981A patent/EP1962817B1/en not_active Not-in-force
- 2006-12-21 UY UY30056A patent/UY30056A1/es not_active Application Discontinuation
- 2006-12-21 DE DE602006018355T patent/DE602006018355D1/de active Active
- 2006-12-21 US US11/614,165 patent/US20070224253A1/en not_active Abandoned
- 2006-12-21 CA CA002633369A patent/CA2633369A1/en not_active Abandoned
- 2006-12-21 PT PT06848981T patent/PT1962817E/pt unknown
- 2006-12-21 DK DK06848981.4T patent/DK1962817T3/da active
- 2006-12-21 PE PE2006001676A patent/PE20071163A1/es not_active Application Discontinuation
- 2006-12-21 MX MX2008008050A patent/MX2008008050A/es unknown
- 2006-12-21 AT AT06848981T patent/ATE488229T1/de active
- 2006-12-21 AR ARP060105700A patent/AR058598A1/es unknown
- 2006-12-21 AU AU2006331596A patent/AU2006331596A1/en not_active Abandoned
- 2006-12-21 WO PCT/US2006/048783 patent/WO2007075883A2/en active Application Filing
- 2006-12-21 EA EA200801575A patent/EA200801575A1/ru unknown
Also Published As
Publication number | Publication date |
---|---|
EP1962817B1 (en) | 2010-11-17 |
AU2006331596A1 (en) | 2007-07-05 |
PE20071163A1 (es) | 2007-11-30 |
PT1962817E (pt) | 2010-12-13 |
WO2007075883A9 (en) | 2007-08-23 |
WO2007075883A2 (en) | 2007-07-05 |
ATE488229T1 (de) | 2010-12-15 |
UY30056A1 (es) | 2007-06-29 |
EP1962817A2 (en) | 2008-09-03 |
CA2633369A1 (en) | 2007-07-05 |
AR058598A1 (es) | 2008-02-13 |
TW200800223A (en) | 2008-01-01 |
WO2007075883A3 (en) | 2008-01-17 |
US20070224253A1 (en) | 2007-09-27 |
DK1962817T3 (da) | 2011-03-07 |
EA200801575A1 (ru) | 2008-12-30 |
DE602006018355D1 (de) | 2010-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2008008050A (es) | Suministro transdermico de meptazinol. | |
IL245290A0 (en) | A medical system for introducing the active substance buprenorphine through the skin | |
MA34133B1 (fr) | Composes pour inhibiteurs de l'immunoproteasome | |
MY183014A (en) | Compounds for enzyme inhibition | |
EA028821B9 (ru) | Соединения и способы для модуляции киназ, а также показания к их применению | |
TN2012000152A1 (en) | Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes | |
MX2011008289A (es) | Tabletas para terapia combinada. | |
ZA201303965B (en) | Transdermal therapeutic system for administering an active substance | |
ZA201005663B (en) | Transdermal therapeutic system having stabilized membrane | |
NZ700356A (en) | Pyrazole compounds as sglt1 inhibitors | |
ZA200809004B (en) | Autodestructive transdermal therapeutic system | |
WO2008022128A3 (en) | Transdermal delivery of meptazinol | |
WO2009138734A3 (en) | Use of opioid compounds in peripheral pain, wound healing and scar formation | |
MX2012002952A (es) | Agente terapeutico para el dolor cronico. | |
WO2011042077A8 (de) | Transdermale therapeutische systeme enthaltend 4-n-butylresorcin | |
UA39947U (ru) | Применение кристалла CdI2:Pb как сцинтиллятора для регистрации б-частиц | |
UA110609C2 (uk) | Сполуки для інгібування ферменту протеасоми | |
UA103224C2 (ru) | Таблетки для комбинированной терапии | |
UA40115U (ru) | Способ лечения глазного ишемического синдрома | |
UA60735U (ru) | Способ оценки адекватности дозы нейропротектора | |
UA46514U (ru) | Способ местного лечения ограниченной склеродермии | |
DK1817029T3 (da) | Isoxazolderivat til lindring af neuropatiske smerter |